Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
40.70
-0.90 (-2.16%)
At close: Nov 17, 2026, 4:00 PM EST
40.60
-0.10 (-0.25%)
Pre-market: Nov 18, 2026, 4:09 AM EST

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $178.97 billion as of November 17, 2026. Its market cap has decreased by 16.54% in one year.

Market Cap
178.97B
Enterprise Value
191.95B
1-Year Change
-16.54%
Global Rank
n/a
Country Rank
n/a
Category

Chart

Chart

Since December 1, 1998, Novo Nordisk's market cap has increased from $5.15B to $178.97B, an increase of 3,371.77%. That is a compound annual growth rate of 13.52%.

History

DateMarket Cap% Change
Nov 17, 2026178.97B-20.84%
Dec 31, 2025226.09B-41.72%
Dec 31, 2024387.95B-17.76%
Dec 29, 2023471.73B54.12%
Dec 30, 2022306.08B19.24%
Dec 31, 2021256.69B55.86%
Dec 31, 2020164.70B16.14%
Dec 31, 2019141.81B23.12%
Dec 31, 2018115.18B-15.84%
Dec 29, 2017136.86B46.79%
Dec 30, 201693.24B-38.18%
Dec 31, 2015150.82B29.59%
Dec 31, 2014116.38B12.48%
Dec 31, 2013103.47B9.30%
Dec 31, 201294.66B36.88%
Dec 30, 201169.16B-0.91%
Dec 31, 201069.79B72.41%
Dec 31, 200940.48B26.82%
Dec 31, 200831.92B-22.43%
Dec 31, 200741.15B52.03%
Dec 29, 200627.07B44.82%
Dec 30, 200518.69B1.87%
Dec 31, 200418.35B29.73%
Dec 31, 200314.14B41.73%
Dec 31, 20029.98B25.01%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Johnson & Johnson687.89B
AbbVie521.50B
Merck & Co.364.26B
Novartis AG302.07B
AstraZeneca286.76B
Amgen251.89B
Gilead Sciences208.48B
Pfizer164.67B
Market Cap Rankings